Debate on Stem Cell Therapy for Pulmonary Fibrosis Heats Up as FDA Hearings Near
COPD, Idiopathic Pulmonary Fibrosis, News
As the U.S. Food and Drug Administration (FDA) readies a public hearing on stem cell therapy regulation, an ongoing debate over the clinical application of stem cell therapy has been heating ... Read more